# A Study of the Use of Text Message Reminders to Take Palbociclib

> **NCT04216576** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 45 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** Paper Drug Diary
- **OTHER:** OhMD APP

## Key facts

- **NCT ID:** NCT04216576
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-12-27
- **Primary completion:** 2026-12-27
- **Final completion:** 2026-12-27
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04216576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04216576, "A Study of the Use of Text Message Reminders to Take Palbociclib". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04216576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*